Accession Number: | 0001437749-23-025479 |
Date: | 2023-09-07 |
Issuer: | UROGEN PHARMA LTD. (URGN) |
Original Submission Date: |
SMITH JASON DREW
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2023-09-07 | deemed execution date | A | 10,000 (a) | ordinary shares 10,000 | $0.00 | 10,000 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit ("rsu") represents a contingent right to receive one ordinary share of the issuer |
f2 | 1/3 of the shares underlying the restricted stock units will vest on each of september 7, 2024, september 7, 2025 and september 7, 2026 |